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1. Introduction 
Prediction of biological activities is valuable for finding active compounds in an effective 
manner, and a considerable amount of attentions has been devoted to in silico predictions in 
drug discovery process. For in silico predictions, quantitative structure-activity relationship 
(QSAR) has been widely known to be useful [1, 2]. The basic purpose of QSAR is to 
construct a statistical model to reveal the relationship between chemical structures and their 
biological activities. For the statistical analysis, chemical structures are usually represented 
by several kinds of chemical descriptors. The QSAR model successfully trained and 
scientifically validated is used for predicting the biological activities of any molecules. In 
addition, a physicochemical and/or mechanistic interpretation can be expected from the 
selected chemical descriptors in the QSAR model.  
As a multivariate statistical method, partial least square (PLS) is of particular interest in 
QSAR study [3]. PLS can analyze data with strongly collinear, noisy and numerous 
descriptors, and also simultaneously model several biological activities. It can also provide 
us several application domains and diagnostic plots as the statistical measures. We can 
extract the complex patterns embedded in the data set. Recently, PLS has evolved or 
changed for copying with sever demands from the complex data structure [4, 5]. 
PLS has its major restriction that only linear relationship can be extracted from data [3]. 
Since many structure-activity data sets are inherently nonlinear in nature, it is desirable to 
have a flexible method, which can model any nonlinear relationships. Recently, there has 
been a considerable interest in machine learning methods (ML) such as Bayesian approach 
[6, 7] and support vector regression (SVR) [8, 9] for nonlinear modeling. In general, since ML 
employs a sort of mathematical transformations of chemical descriptors, they have 
drawback that any correlations between the biological activity and the original descriptors 
should be lost. This means that a direct interpretation of the model is not easy task. A lot of 
papers studying ML have reported their high performances for classification and regression 
rates, but unfortunately they have not referred to the aspect of chemical interpretation [10].  
For chemical interpretation, we employed the extended connectivity fingerprint (ECFP) as 
the chemical descriptor for a statistical model. ECFP can facilitate to understand what 
substructures are correlated with a specific biological activity. An atom score was calculated 
from the degree of contribution of each substructure to the model. By visualizing the atom 
scores with the graded-colors, an atom color mapping onto each compound was performed. 
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The atom coloring is helpful as a starting point for further molecular design with the 
guidence of atom colors. We described herein two representative examples for application 
of atom colors. (classifiaction of cytochrome P450 substrates and non-substrates, and 
visualization of molecular selectivity in dopamine family) 
After establishing a solid model, de novo design is available for exploring new chemical 
structures in computer-aided molecular design. Structure generator intended for de novo 
design generates any chemical structures that are expected to have desired biological 
activities. This study has been known as inverse QSAR [11, 12].  
In our approach, EA-Inventor (Evolutional Algorithm-Inventor) was used as structure 
generator. In EA-Inventor, initial structures represented by SMILES string are modified 
using several mutation operations in the framework of evolutionary algorithm (EA). 
Biological activities of compounds are predicted by the prepared QSAR model, and their 
values are used as the score values in EA. After the EA cycles, i.e. prediction of biological 
activities and generation of new chemical structures, chemical structures that have the 
highest scores are obtained. We applied our de novo design method to two molecular design 
projects and demonstrated its utility. (de novo design using ligand-based descriptors, and 
protein-ligand interaction descriptors) 
2. Examples of atom coloring 
2.1 Classification of CYP 3A4 substrates and non-substrates  
Besides an optimization of biological activity, we have to consider to avoid poor ADMET 
(absorption, distribution, metabolism, excretion, and toxicity) properties of molecules. 
ADMET processes often involve interaction with the associated proteins [13]. For example, 
the cytochrome P450 (CYP) isoenzymes, such as CYP 3A4, 2D6, and 2C9, are responsible 
proteins for the metabolism of most drug molecules. Among them, CYP 3A4 is the most 
important metabolism protein in human because it metabolizes the majority of 
commercially available drug molecules. Therefore, prediction of CYP 3A4 substrates is a key 
task to be solved in molecular design [14].  
We employed the Bayesian approach to classify CYP 3A4 substrates and non-substrates. 
Large public data set comprising of 600 data points was used to develop the Bayesian 
model. The extended connectivity fingerprint (ECFP) was used as chemical descriptor. ECFP 
can facilitate to understand what substructures are correlated with substrates or non-
substrates. An atom score in molecule was calculated from the Bayesian score of each ECFP 
descriptor. By coloring the atom scores with the five graded-colors, an atom color mapping 
onto each molecule was performed. The atom coloring is an effective tool for chemical 
interpretaion why a specific compound becomes a CYP 3A4 substrate and what chemical 
parts are responsible causing CYP 3A4 metabolism.  
2.1.1 Bayesian model 
The data set of CYP 3A4 substrates and non-substrates was taken from a public literature 
[15]. According to the literature, we divided whole data set into the training and test sets. 
The separation was performed taking considerations of their distribution in chemical space. 
The total number of substrates and non-substrates are 311 and 289 in the training set, 
respectively. The total number of substrates and non-substrates are 56 and 44 in the test set, 
respectively. Also, we made further external validation experiment to our prediction model 
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of CYP 3A4 oxidation sites [16]. All of these molecules are known to be CYP 3A4 substrates. 
The number of molecules in the external validation set is 61 
Bayesian model was constructed through the Pipeline Pilot module in Accelrys [17]. 
Bayesian approach compares the frequency of occurrences of chemical descriptors that are 
found in two groups that discriminate best between these groups (CYP 3A4 substrates 
versus non-substrates) [6, 7]. ECFP_6 (ECFP with path-lengths of six) was calculated in the 
Pipeline Pilot module and it was used as chemical descriptor. ECFP is a novel class of 
topological fingerprints for molecular characterization [18]. The Bayesian model for CYP3A4 
classification provided us 12595 unique bins in ECFP_6. The base-line value separating 
between substrates and non-substrates is -0.819. Therefore, if the score of a compound is 
greater than this value, the compound is predicted to be substrate. Otherwise, the 
compound is predicted to be non-substrate. The classification rates of substrates and non-
substrates in the training set are 285/311 (92%) and 280/289 (97%), respectively. The 
prediction rates of substrates and non-substrates in the test set are 47/56 (84%) and 37/44 
(84%), respectively. The performance of the Bayesian model is well tolerated for further 
prediction. The established Bayesian model was applied to the CYP 3A4 substrates in the 
external validation set from our prediction model of CYP 3A4 oxidation sites [16]. The 
prediction rate is 53/61 (87%). The prediction rates from two external validation 
experiments are high enough to use as a prediction filter in early stage of molecular design.  
2.1.2 Atom colorings 
An atom scoring is a method to calculate a score value of each atom in molecule based on 
the Bayesian score [19]. First, a Bayesian model is built and the corresponding ECFP_6 
descriptors are scored and categorized as substrate or non-substrate features. The score 
value of each ECFP substructure is divided by the number of heavy atoms consisting of the 
substructure and the calculated score value is assigned on each atom. Then, substructures of 
test molecule are identified, and the respective scores of atoms in the substructure are 
summed up and divided by the number of frequency occurrence to calculate their averaged 
atom scores. The schematic illustration for calculating atom scores is shown in Figure 1. An 
example in Figure 1 is ‘Dutasteride’ containing the amide substructure. The amide 
substructure is mapped on ‘Dutasteride’ and the corresponding atom scores (C4, C8, N13, 
and O14) are summed up.  
 
 
Fig. 1. Schematic illustration for calculating atom scores with example ‘Dutasteride’ 
www.intechopen.com
 Knowledge-Oriented Applications in Data Mining 
 
170 
Four thresholds were used to color atoms in the five graded-colors (0.02, 0.01, -0.01, and -
0.02). Because a higher score means a highly likelihood of CYP 3A4 substrate, the atom 
coloring is blue for higher, and red for lower susceptible to the CYP 3A4 metabolism. The 
representative examples of atom coloring are shown in Figure 2. In this figure, blue colors 
mean the liable atoms against CYP 3A4 metabolism. As for ‘Adinazolam’, tertiary N atom is 
identified to be liable atom. As for ‘Clarithromycin’, both of tertiary N atom and ethyl 
substituent on the macrocyclic ring are identified to be liable atoms. These predictions 
exactly match with the experimental results. Medicinal chemists can think any new ideas 
how to avoid the risk factors with the guidance of the atom coloring map.  
 
 
 
Adinazolam                                                    Clarithromycin 
Fig. 2. The representative examples of atom coloring (‘Adinazolam’ and ‘Clarithromycin’) 
Our approach is quite simple and it can be extended to other ADMET issues than CYP 
metabolism. The classification category between good and bad ADMET properties is 
prepared in advance and the Bayesian approach and the associated atom colorings are 
subsequently applied. From the atom colorings, we can easily identify unfavorable atoms in 
chemical structure for each ADMET property. 
3. Visualization of molecular selectivity in dopamine family 
In molecular design, computational methods that are capable of analyzing and predicting 
ligand selectivity profiles within target families are highly attractive [20]. This is the reason 
why molecules having activities against multi-target proteins cause many unfavorable side 
effects and toxicities. From the point of safety, data mining such as visualization of 
molecular selectivity against multi-target proteins cannot be ignored in molecular design 
[20].   
Molecular selectivity was visualized using the combination of activity landscapes and atom 
colorings. The multiple inhibitory activites in dopamine family were selected to derive its 
molecular selectivity. At first, all of 390 molecular structures were mapped on 2D chemical 
space by preserving distance between any pairs of molecules using multi-dimensional 
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scaling (MDS). The inhibitory activity values against each dopamine isoenzyme (D2, D3, 
and D4) were added independently to the data points in 2D chemical space. Activity 
landscapes were generated after making the color-graded interpolation between the data 
points. We can easily identify three specific active regions and the corresponding 
representative molecules for D2, D3, and D4 isoenzymes. Next, three support vector 
regression (SVR) models were separately built up using the above-mentioned ECFP 
descriptors and each inhibitory data set. By applying an atom coloring method to the 
representative molecules, the molecular selectivity differentiating each dopamine isoenzyme 
can be visually understood. Finally, the obtained molecular selectivity was validated from 
3D homology structures. 
3.1 Activity landscapes 
Activity landscapes are defined by distance between any pairs of molecules and their 
biological activities [21]. If we envision a 2D projection of chemical space with the graded 
coloring of biological activity, this representation becomes reminiscent of geographical map 
that can readily be interpreted. The distance of two molecules is calculated as the Euclidean 
distance between their ECFP_6 descriptors. The Euclidean distance is defined according to 
the following equation [21]: 
 2ij i j ijN N Nδ = + −  (1) 
where Ni and Nj denote the number of ECFP_6 binary bins present in molecules i and j, 
respectively. Nij denotes the number of binary bins shared by both molecules. To map multi-
dimensional data into 2D chemical space, MDS is employed. MDS aims at preserving 
relative similarity relationships between input data points by minimizing the deviation from 
the ideal relationships [22]. 
Biological activity values are then added to the data points in 2D chemical space for creating 
activity landscape. In general, however, the data points are sparse and unevenly distributed 
and must be interpolated to obtain coherent chemical space. For this purpose, a 
geostatistical technique termed Kringing is applied. Based on the expected value and a 
covariance function that describe the spatial dependence of the given data points, the 
Kringing method calculates the best linear unbiased estimator by minimizing the variance of 
the prediction error. We utilize the Kringing function as implemented in the ‘fields’ package 
of R [23]. After finishing the interpolation, 2D map is colored according to the predicted 
activity values. Areas with a value below a lower threshold are colored in blue, and areas 
with a value above an upper threshold are colored in red. Intermediate values are colored 
using a continuous gradient from blue via yellow to red. 
We collected three inhibitory data sets of D2, D3, and D4 from GVK data base [24]. The 
logarithm of reciprocal value of Ki in the micro molar unit (log(-Ki)) was used as the 
inhibitory activity. We selected 390 molecular data points for filling all elements in three 
inhibitory data matrices. Three activity landscapes of D2, D3, and D4 are shown in Figure 3. 
In Figure 3, the region showing both high inhibitory activity and high specificity toward 
each dopamine isoenzyme was highlighted by the dashed circle. The representative 
molecules are shown beside each activity landscape. Three molecules have the common 
tertiary N atoms in their chemical structures to interact with the common Asp in their target 
dopamine proteins [25]. However, chemical fragments at two ends in molecule significantly 
differ to each other. They are reflected on the molecular specificity in dopamine family. 
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                  D2 activity landscape                                          D3 activity landscape 
 
 
 
  
 
  
 
       
                             D4 activity landscape 
     
Fig. 3. Three activity landscapes and the representative molecules  
3.2 SVR models 
SVR was used to develop the predictive model for each dopamine isoenzyme using ECFP_6 
descriptors. SVR is a regression type of support vector machine (SVM) by the introduction 
of a loss function comprising of the squared deviations [8-10]. The general principle of SVM 
is to perform a classification by constructing an n-dimensional hyper plane that optimally 
separates the data set into two categories.  
Before SVR analysis, 3859 ECFP_6 descriptors were reduced to 82 by the filter of variance 
cut off of 0.1 After that, a systematic grid search was used to determine the best parameter 
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values for D2 data set based on 10-fold cross-validation (C=2, ν=0.30, and γ=0.03125). The 
procedure of backward-elimination was applied to produce the final D2 model with 44 
descriptors. The R2 and Q2 values of the final D2 model are 0.782 and 0.615, respectively. 
The same procedures were applied to D3 and D4 data sets. As for D3, the final model has 45 
descriptor with C=2, ν=0.35, and γ=0.03125. The R2 and Q2 values of the final D3 model are 
0.900 and 0.783, respectively. As for D4, the final model has 40 descriptor with C=1, ν=0.55, 
and γ=0.03125. The R2 and Q2 values of the final D4 model are 0.793 and 0.637, respectively. 
All statistical procedures were performed using the ‘kernlab’ package of R [26] and some 
written scripts in our laboratory. 
3.3 Atom colorings 
After building each SVR model, a local gradient was calculated according to the following 
formula: 
 
( )|
iij j x x
w f x
x
=
∂⎛ ⎞= ⎜ ⎟∂⎝ ⎠  (2) 
where i means index of compounds. J means the index of ECFP_6 descriptors. The value of 
local gradient indicates the descriptor importance in a specific compound. For a specific 
compound i, the value of descriptor j is slightly changed keeping other descriptor values to 
be fixed. Then, the differences of the predicted values from the SVR model are calculated. 
The local gradient is derived from the differences divided by the shifted values. The original 
idea of local gradient came from the financial study [27]. One of authors (K. Migita) has 
made further invention for improving the calculation efficacy and precision [28]. The value 
of local gradient of each substructure was used as the Bayesian score value for next atom 
coloring. The calculation of local gradient was performed using the written scripts in our 
laboratory under the R environment. 
The atom colorings of each specific dopamine inhibitor are shown in Figure 4. Four 
thresholds were used to color atoms in the five graded-colors (0.008, 0.004, -0.004, and -
0.008). The atom coloring scheme is blue for the most contributed atom to the inhibitory 
activity, and red for least. As shown in Figure 4, compound 6111240 is a specific inhibitor 
toward D2 protein and this is emphasized in the remarkable blue and green colors. 
Compound 6111240 has unfavorable amide part toward D4 protein, which are highlighted 
in red color. Other specific compounds (10161 and 39839) also show clear molecular 
specificity owing to the atom colorings. 
These molecular specificities were validated by 3D structures of D2 and D4 proteins. The 3D 
structures were built by the homology modeling procedure based on the template X-ray 
crystal structure of β2 (PDB code: 2RH1). The 3D coordinates of homology structures of D2 
and D4 proteins were cited from a recent public study [25]. In Figure 5, 3D structures of D2 
and D4 proteins are shown with a specific compound 6111240. Cyan and white colors 
represent D2 and D4 protein structures, respectively. Compound 6111240 is shown in 
yellow bold color. The compound has nice polar interactions with Asp 114 and Cys 118 
residues in D2 protein. However, in the case of D4 protein, due to the bulky residues (Phe 91 
and Arg 186), compound cannot maintain the polar interactions in D4 protein. This could be 
one of reasons why compound 6111240 has high molecular specificity only toward D2 
protein. Different coloring patters on amide part are nicely accordance with the differences 
of active site pockets between D2 and D4 proteins.  
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GVK_ID: 6111240 
 
D2 = 10.07,                   D3 = 9.22,                             D4 = 6.68 
GVK_ID: 10161 
 
D2 = 6.43,                   D3 = 9.89,                            D4 = 6.14 
GVK_ID: 39839 
 
D2 = 7.25,                    D3 = 6.62,                             D4 = 9.22 
Fig. 4. Atom colorings of each specific dopamine inhibitor 
 
   
Fig. 5. Two homology models and their interactions with compound 6111240 
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Including biological activity, the landscape technique can be applied to multiple ADMET 
endpoints. This makes help us identify some interesting chemical space where compounds 
show high biological activity and also satisfy good ADMET properties. We are planning to 
construct graphical user interface (GUI) handling many landscape panels [29]. When 
medicinal chemists touch a data point in a specific landscape, the associated data is shown 
immediately with a chemical structure. This system might be a good compass to know us 
where synthetic compounds are in chemical space or what extent of chemical efforts is 
necessary to achieve chemical optimization. 
4. Examples of de novo design 
4.1 De novo design using ligand-based descriptors 
QSAR has been successfully applied in molecular design [30]. However, when a precise 
QSAR model is created, chemical interpretation generally becomes difficult. In particular, in 
the case of a non-linear model, the relationship between chemical descriptors and biological 
activity cannot be described explicitly, and chemical interpretation becomes challenging 
[31]. In this case, an inverse QSAR approach is attractive to design practical chemical 
structures. Inverse QSAR is a relatively new concept that chemical structures having high 
biological activities are computationally generated using a structure generator [11, 12]. 
EA-Inventor (Evolutionary Algorithm-Inventor) was used as structure generator in our 
study. In EA-Inventor, chemical structures are updated using several mutation operations in 
an iterative manner to achieve high inhibitory activities. We applied EA-Inventor to the data 
set of 33 matrix metallopeptidase 2 (MMP-2) inhibitors. The scoring function for input to 
EA-Inventor is the prediction value derived from the SVR model. In order to prevent 
generated structures deviating from chemical space, the leverage value was added to the 
scoring function as the penalty value. The generated chemical structures are reasonable 
judging from 3D homology structure of MMP-2 protein as their counterparts.  
4.2 EA-Inventor 
EA-Inventor has been successfully applied along with the docking algorithm [32]. In our 
study, EA-Inventor was used in combination with prediction value derived from a specific 
QSAR model. Initial chemical structures are set up as a SMILE string. As mutation 
operations to chemical structures, 33 different transformations are available in EA-Inventor. 
Some typical transformations are shown in Figure 6. Transformations (i) and (ii) involve 
changing the atoms and bonds, respectively. Transformations (iii) and (iv) involve breaking 
the ring structure and changing the ring size, respectively. Transformation (v) involves the 
addition of the prepared chemical fragments in advance. Around 1400 libraries of fragments 
have been compiled by breaking down the chemical structures of drug-like molecules. 
Therefore, new chemical structures, including those of drug-like compounds, can be formed 
by combining these fragments [33]. The algorithm of EA-Inventor is schematically shown in 
Figure 7. The experiment of EA-Inventor was performed on the Sybyl environment [34].  
4.3 SVR model 
The data set of 33 MMP-2 inhibitors were collected from a literature [35] and the SVR model 
was developed with 496 ligand-based descriptors. These descriptors were calculated by the 
descriptor module in MOE [36]. After pre-processing of descriptors based on variance cut 
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and p-values (0.1 and 0.01), 26 descriptors were selected. Then, a grid search based on leave-
one-out cross-validation was performed to determine the best parameter values 
(C=64, ν=0.15 and γ=0.008). The procedure of backward-elimination was applied to produce 
the final SVR model with 15 descriptors. The R2 and Q2 values of the final SVR model are 
0.867 and 0.795, respectively. The selected 15 descriptors have the ambiguous 
physicochemical meanings and their chemical interpretations are far to be ease. In this 
situation, an inverse QSAR becomes a powerful approach [11, 12]. 
 
(i) (ii) 
  
  
(iii) (iv) (v) 
 
Fig. 6. Typical transformations in EA-Inventor: (i) modification of atom type, (ii) 
modification of bond type, (iii) breaking of ring, (iv) modification of ring size, (v) addition of 
fragment. 
 
 
Fig. 7. Algorithm of EA-Inventor as structure generator. 
4.4 De novo design 
With fixing the core scaffold structure, EA-Inventor was performed with 100 populations 
and 20 generations in 10 runs. The output of generated chemical structures is shown in 
Figure 8. In Figure 8, symbol a means the predicted inhibitory activity. Symbol b means the 
leverage value. All of the generate structures have both of high predicted inhibitory 
activities and low values of leverage.  
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There are two ways for making validation about the output structure from de novo design: 
One is that actually synthesizing compounds and measuring their inhibitory activities. 
Other is that comparing the output structure with the target structure. Because we are not 
available on experimental way, we employed the latter approach for validation of our 
results. In Figure 9, the binding mode of one of examples (benzothiazole molecule) in the 
pocket of MMP-2 homology model is shown. Homology model of MMP-2 was built from a 
complex X-ray structure between MMP-12 and hydroxamate ligand (PDB: 1RMZ). White 
and orange colors represent MMP-2 protein and benzothiazole molecule, respectively. 
Benzothiazole molecule has the good interactions with Val 400, His 403, and Tyr 425 
highlighted in red colors. Then, it is highly expected from the protein-ligand interactions 
that the benzothiazole molecule could show the high inhibitory activity. All of the fused 6-5 
or 6-6 ring systems exemplified in Figure 8 are favorable to occupy the cavity pocket in 
MMP-2 protein. These results indicate that EA-Inventor can actually generate new chemical 
structures with the high inhibitory activities.  
 
 
Fig. 8. Output of generated chemical structures from EA-Inventor  
 
           
Fig. 9. Docking mode of benzothiazole molecule in MMP-2  
N
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We can consider the chemical structures cited in Figure 8 as the starting molecules. For 
example, ‘benzothiazole’ and ‘indole’ can be transformed to any aromatic rings such as 
benzofuran. It is rationale transformation from five member ring ‘pyrolidine’ to six member 
ring ‘piperidine’. Therefore, the proposed chemical structures from EA-Inventor are good 
hints for further molecular design. 
4.5 De novo design using protein-ligand interaction descriptors 
Structure-based drug design (SBDD) is a technique for designing novel compounds by use 
of physico-chemical interactions in a complex X-ray structure between a protein and a 
ligand molecule [37]. The most important thing for SBDD is an accurate estimation of 
binding affinity of the ligand molecule against the target protein. This issue has not been 
solved accompanying with prediction of docking pose of molecule in the protein structure. 
Therefore, for a specific target protein, the scenario that the docking scoring function is 
customized in the framework of QSAR is highly attractive [38]. The integration of the 
customized docking scoring function into de novo design engine is interesting for designing 
potent molecules more accurately than those of traditional SBDD.   
We customized the docking scoring function using comparative molecular binding energy 
(COMBINE) descriptors and SVR. COMBINE descriptors are energy terms between the 
ligand molecule and each amino acid residue of the target protein. The data set of 35 human 
caspase-3 inhibitors was used in our study. The SVR model can successfully identify 
important amino acid residues for explaining inhibitory activities against human caspase-3. 
Then, we integrated the docking scoring function into EA-Inventor. A number of molecules 
were virtually generated by EA-Inventor, and they were evaluated using the customized 
docking scoring function. EA-Inventor produced some interesting compounds and the 
rationale was validated using X-ray crystal structure of human caspase-3. 
4.6 SVR model 
The data set of 35 human caspase-3 inhibitors focusing Isatin sulfonamide analogues was 
taken from a literature [39]. COMBINE descriptors expressing the protein-ligand 
interactions were used as chemical descriptors [40, 41]. From the X-ray crystal structure of 
human caspase-3 (PDB code: 1GFW), total 47 amino acids were detected as the nearest 
amino acids forming the binding pocket. Since van der Waals, Coulomb, and hydrogen 
bonding interaction energies are considered, and total number of COMBINE descriptors 
becomes 141. All of 35 inhibitors were docked into human caspase-3 structure and 
COMBINE descriptors were calculated by the GLIDE docking module [42]. After pre-
processing of descriptors based on variance cut of 0.05, 29 significant descriptors were 
selected. A grid search based on leave-one-out cross validation was used to determine the 
best parameter values (C=4, ν=0.95 and γ=0.03125). The procedure of backward-elimination 
was applied to produce the final SVR model with 13 COMBINE descriptors. The R2 and Q2 
values of the final SVR model are 0.977 and 0.873, respectively.  
The selected 13 COMBINE descriptors are as follows in the descending order of the above-
mentioned local gradient values: His 121 vdw, Met 61 vdw, Ser 251 hbonds, Glu 123 coul, 
Phe 250 vdw, Ser 251 vdw, Asp 253 coul, Arg 207 vdw, Phe 256 vdw, Asn 208 coul, Tyr 204 
coul, Tyr 204 vdw, and Lys 259 coul. Three abbreviations (vdw, coul, and hbonds) mean van 
der Waals, Coulombic, and hydrogen bonding interactions, respectively. Many COMBINE 
descriptors are derived from the van der Waals interaction. The presumed binding mode of 
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compound 21 in human caspase-3 is shown in Figure 10. White and green present the 
caspase-3 protein and compound 21, respectively. The selected amino acid residues in the 
final SVR model are highlighted in yellow bold colors in Figure 10. They are located close to 
two ends of chemical structure in compound 21. 
 
 
Fig. 10. Presumed binding mode of compound 21. 
4.7 De novo design 
With fixing the core scaffold structure, EA-Inventor was performed with 50 populations and 
3 generations in 10 runs. The output of generated chemical structures from EA-Inventor is 
shown in Figure 11. The number below each chemical structure means the inhibitory 
activity predicted by the SVR model. The generated chemical structures are mainly 5 and 6-5 
fused ring systems. In order to validate the output structures, they were docked into the X-
ray crystal structure of human caspase-3. The presumed binding mode of indole molecule is 
shown in Figure 12. Three strong interactions with the indole part of molecule are 
highlighted in red colors: CH-π interactions of side chains of Glu 123 and Met 61, and π-π 
interaction of imidazole ring of His 121. These amino acid residues are included in the 
selected 13 COMBINE descriptors. Judging from these 3D molecular interactions, 6-5 fused 
ring analogues seems to be highly expected for high inhibitory activity.  
 
 
Fig. 11. EAInventor for producing chemical structures. 
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Fig. 12. Presumed binding mode of indole molecule. 
Thanks to the transparent COMBINE descriptors, medicinal chemists can easily find which 
amino acid residues or which types of interactions are important for increasing inhibitory 
activity. Medicinal chemists can focus on the specific chemical parts interacting with these 
important amino acid residues. Their chemical parts are effectively replaced by another 
moiety using de novo design engine.  
5. Conclusion 
Two techniques of atom coloring and de novo design were introduced with their 
representative examples. By coloring atom scores derived from the Bayesian or SVR models 
with the five graded-colors, we can easily identify the key atoms in chemical structure 
responsible to each biological activity. The visualization encourages us to think design ideas 
how to modify chemical structure in next synthetic plan. De novo design provides us 
chemical structures with high inhibitory activities in the framework of QSAR. The generated 
chemical structures are good starting molecules for further molecular design.  
As mentioned before, the landscape technique is useful to grasp rough trend in whole 
chemical space. The combination of landscape with de novo design engine is especially 
attractive as new strategy of molecular design. At first, we select an interesting region in 
chemical space. The interesting region means that it contains a chemical structure with high 
biological activity and good ADMET properties. Any chemical structures are virtually 
generated starting from the chemical structure in the region. During de novo simulation, the 
generated chemical structures are forced to stay inside the region. After that, chemical 
structures with same chemical profile as that of the starting molecule could be found 
according to this scenario. This study is in progress and the results will be disclosed in near 
future [43].   
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